ArticleCancer management and research2024

The Efficiency and Safety of Triple-Drug Combination of Albumin-Bound Paclitaxel, Anlotinib and PD-1/L1 Inhibitors in the 2

Xiaobing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.